Fierce Pharma

AUGUST 28, 2023

With seven posters and nine presentations on Farxiga over the weekend at the European Society of Cardiology (ESC) scientific sessions in Amsterdam, AstraZeneca made it clear that it has lots to say | As AstraZeneca's Farxiga has added four indications over the last five years—on top of its initial 2014 approval for Type 2 diabetes—its spillover (..)

230

230

World of DTC Marketing

JANUARY 4, 2022

In 2014, cancer patients paid $4 billion out-of-pocket for cancer treatment. Pharma companies are aware that insurers will rarely say no to new cancer therapies, but increased scrutinization of early approvals is on the horizon. Some cancer patients may face out-of-pocket costs of nearly $12,000 a year for one drug.

Insurance 273

Insurance Transportation Medical Medicine 273

World of DTC Marketing

DECEMBER 17, 2020

The health insurance, PBM’s, and big pharma didn’t accumulate their massive wealth by running deficits. Another 8% said they or a family member put off treatment for a less serious condition, bringing the total percentage of households delaying care due to costs to 33%, tying the high from 2014.

Healthcare 181

Healthcare Healthcare Government Physicians 181

European Pharmaceutical Review

FEBRUARY 28, 2025

For documents published in 2014 this number was just six; in 2024 it was 157 ( Figure 2 ). 2014-2024 (Credit: Elsevier BV – Scopus) Figure 2 : Documents by year. 2014-2024 (Credit: Elsevier BV – Scopus) Regionally, the US is dominating rare disease research. What solutions should pharma professionals focus on?

Education 88

Education Patients Medicine Pharma 88

pharmaphorum

NOVEMBER 2, 2022

Citeline provides intelligence, data and software for clinical trials, development and regulatory compliance and was formerly part of Informa was called Pharma Intelligence ahead of a rebranding earlier this year. The post Norstella, Citeline merge to create $5bn pharma tech firm appeared first on.

Pharma 101

Pharma Marketing Patients Consulting 101

European Pharmaceutical Review

SEPTEMBER 12, 2023

As part of The Future of Pharma/Biopharma Analysis 2023 , which took place on 28-29 June 2023, European Pharmaceutical Review ( EPR ) gathered an expert panel to discuss developing a modern contamination control strategy. Early adopters started putting these strategies together around 20 years ago.

Consulting 128

Consulting Biopharma Manufacturing Pharmaceutical 128

European Pharmaceutical Review

OCTOBER 20, 2022

1 The last four are produced at separate plants and thus less discussed for pharma since they are unlikely to be producing them in house. Water quality from an Annex 1 and Pharma 4.0 Making the journey to PAT and Pharma 4.0. In particular, purified water and WFI are critical when producing sterile pharmaceutical drug products.

Food and Drug Administration 98

Food and Drug Administration Pharma Manufacturing Pharmaceutical 98

pharmaphorum

DECEMBER 15, 2022

A pharma industry organisation has warned that record levels of revenue clawback from the UK government is threatening “footprint, R&D and manufacturing investments” in the country. ” The post Pharma says VPAS clawback jeopardises UK sector appeared first on. The increase to 26.5% VPAS tax on top.

Pharma 72

Pharma Government Manufacturing Medicine 72

Evolve Your Success

JUNE 28, 2022

Pharma Sales To Med Device CEO: The Jeff Smith Story Part 2. This was from 2008 to 2014. By 2014, we were on our way with Providence. In 2014, it was clear that Thayer was going to be hard. The post Pharma Sales To Med Device CEO: The Jeff Smith Story Part 2 appeared first on Evolve Your Success. Love the show?

Sales 130

Sales Pharma Medical sales reps Medical sales 130

pharmaphorum

NOVEMBER 27, 2022

A group representing pharma companies selling precision therapies for cancer has called for a change to the way genomic testing is done in Scotland, to make sure patients get access to targeted drugs. “It would have saved me and the NHS a lot of money. It would have avoided false hope.”

Patients 104

Patients Medicine Government Leads 104

pharmaphorum

OCTOBER 26, 2022

When people think about pharma, they often think about “big” pharma: large, faceless corporations. Every pharma company developing treatments for new diseases is contributing to some degree to better global health. The post How one pharma “family business” places patients first appeared first on.

Patients 96

Patients Pharma Consulting Transportation 96

World of DTC Marketing

MAY 26, 2021

net revenue for Imbruvica has increased from $492 million in 2014 to $4.3 billion in Imbruvica net revenue from Medicare Part D between 2014 and 2018. AbbVie’s yearly U.S. net revenue from Humira more than tripled from $5.3 billion in 2013—the year it separated from Abbott—to $16.1 billion in 2020. billion in 2020. AbbVie’s U.S.

Competition 180

Competition Marketing Government Patients 180

Pharma Leaders

MAY 30, 2023

Italy-based Abiogen Pharma has announced the acquisition of a 97.09% stake in Switzerland-based EffRx Pharmaceuticals. Abiogen Pharma’s business spans across many integrated aspects : research and development, manufacturing of pharmaceuticals under its own brand or third-party contracts, and marketing of its own and licensed drugs.

Pharmaceutical 52

Pharmaceutical Pharma Distribution Prescription 52

pharmaphorum

SEPTEMBER 5, 2022

The UK Competition and Markets Authority (CMA) is seeking to disqualify Peter Butterfield, currently chief executive of Alliance Pharma, from serving as a company director. Medreich obtained a licence to supply prochlorperazine in January 2014, but did not start to supply the product until late 2017.

Pharma 59

Pharma Competition Management Marketing 59

pharmaphorum

SEPTEMBER 14, 2022

Baumann pushed through the Monsanto deal, despite resistance from some Bayer shareholders who were concerned it was buying a struggling business and could be diverted from its higher-margin pharma focus. The post Report claims Bayer is already hunting for a new CEO appeared first on.

Pharma 98

Pharma Management Leads Marketing 98

Clarivate

OCTOBER 31, 2023

What do the years 2001, 2007, 2014, and 2022 have in common? These years witnessed significant troughs in pharma financing, a drop in the capital markets, and an IPO window that remained firmly shut. In short, the biotech bubble had burst. Pfizer’s $11.6 Pfizer’s $11.6

Pharma 52

Pharma Biopharma Marketing Healthcare 52

pharmaphorum

NOVEMBER 6, 2022

Naturally, the pharma industry has seen an explosion of mAbs in the pipeline, which has led to the evolution of new methods for improving and refining the antibody pipeline. Four leading pharma companies – AstraZeneca, Merck, Pfizer, and Teva – along with Amazon Web Services, Inc. billion, plus royalties.

Biopharma 123

Biopharma Pharma Training Leads 123

pharmaphorum

JULY 9, 2014

The global pharmaceutical market passes a significant milestone in 2014: reaching one trillion US dollars in total value.

Marketing 52

Marketing Digital Media Pharma Engineering 52

pharmaphorum

JUNE 27, 2016

As a snapshot, 2014 saw 40,000 tweets and 140m+ impressions over the conference days, 2015 grew to 60,000 tweets and 250m+ impressions and the 2016 buzz is already louder and more plentiful than last year.

Media 52

Media Medical Pharma 52

Pharmaceutical Technology

FEBRUARY 22, 2023

The patent battle between Amgen and Sanofi over their cholesterol-lowering antibodies has divided big pharma in the past months. Amgen sued the two companies in 2014 over supposed patent infringement. This case has broader implications for pharma as an industry, which explains the interest from other businesses.

Pharma 104

Pharma Government Sales FDA 104

Pharma Marketing Network

JULY 17, 2023

He joined Ogilvy in 2014, as the Chief Digital Officer for Ogilvy CommonHealth, the specialist health care agency within the Ogilvy Group. Twitter: @ritters90 Website: ogilvyconsulting.com Linkedin: [link] The post Ritesh Patel appeared first on Pharma Marketing Network.

Consulting 52

Consulting Education Networking Healthcare 52

European Pharmaceutical Review

JANUARY 18, 2024

GlobalData anticipated it will launch in the US and 5EU (France, Germany, Italy, Spain, and the UK) markets during the forecast period, Sulayman Patel, MSci, Pharma Analyst at GlobalData noted. “As

Marketing 98

Marketing Sales Pharmacology Pharma 98

pharmaphorum

OCTOBER 5, 2022

This time last year, the pharma giant published two whitepapers on the topic, setting out proposed frameworks for valuing combination treatments and for compliant inter-organisation arbitration. This access conundrum was acknowledged by NICE as far back as 2014, and has been sitting in pharma’s “inbox” for some time.

Medicine 98

Medicine Competition Patients Marketing 98

pharmaphorum

SEPTEMBER 14, 2016

Video content accounted for 64% of all the world’s internet traffic in 2014 and is expected to grow to 80% by 2019. As the way in which we connect and digest information evolves, high quality mobile video capture and advanced digital analysis offers ever more authentic, intimate and rich insights into the customers’ world.

Pharma 52

Pharma 52

Pharmaceutical Technology

MAY 30, 2023

The Italian pharmaceutical company Abiogen Pharma completed an acquisition of a 97.09% stake in the Swiss orphan conditions-focused EffRx Pharmaceuticals on May 29. Abiogen Pharma specialises in osteoarticular and bone metabolism diseases amongst other therapy areas.

Pharmaceutical Distribution 52

Pharmaceutical Distribution Distribution Medicine Pharmaceutical 52

PM360

AUGUST 29, 2022

That was 2014. Whether its big pharma working with advocacy groups or biotech working with smaller organizations, it’s indisputable that industry’s most trusted PAO partners shaped policy and catalyzed research in ways that have led to significant improvements in many lives.

Patients 98

Patients Ethics Insurance Recruitment 98

pharmaphorum

NOVEMBER 14, 2022

A study of public tenders for prescription medicines between 2014 and 2019 shows a fall in multi-criteria tenders rewarding “environmental” attributes and an average weighting of only 5% (see Figure 2). Where tenders are concerned, greater weight should be given to sustainable criteria, which is well understood, but poorly implemented.

Medicine 105

Medicine Pharmaceutical Healthcare Healthcare 105

pharmaphorum

NOVEMBER 11, 2022

Viehbacher led Sanofi between 2008 and 2014 and has decades of experience with both large pharmaceutical companies and small biotechs. However, in 2014 Sanofi fired Viehbacher over a boardroom fight regarding his management. — Bloomberg (@business) November 10, 2022.

Insurance 40

Insurance Doctors FDA Pharma 40

pharmaphorum

JANUARY 9, 2023

It also has potential in NDD, although it was discontinued as a treatment of fragile X syndrome in 2014 after disappointing phase 2b trial results. STP-2 was licensed from Evgen Pharma in October last year.

Pharma 59

Pharma Patients Medical Marketing 59

pharmaphorum

DECEMBER 29, 2022

The case revolves around allegations that Novartis made an agreement in 2011 with Par Pharmaceutical when Exforge (valsartan/amlodipine) was nearing the end of its patent life that was designed to keep Par’s generic version of the drug off the market until 30 September, 2014.

Retail 52

Retail Marketing Doctors Government 52

pharmaphorum

JANUARY 16, 2023

Two top pharma companies have exited the UK’s voluntary medicines pricing agreement in protest at what the industry has said is a “punitive” system of revenue clawbacks, casting doubt on the future of the scheme in its present form. in 2022.

Government 69

Government Medicine Consulting Management 69

pharmaphorum

DECEMBER 16, 2022

The Switzerland-based business was set up in 2014 as a neuroscience specialist, developing drugs for indications like Alzheimer’s disease, Lewy Body dementia, and rapid eye movement (REM) sleep behaviour disorder.

Distribution 59

Distribution Pharma 59

pharmaphorum

NOVEMBER 22, 2022

Francis, who is currently CEO of gene therapy specialist Purespring Therapeutics and cardiovascular drug developer company Forcefield Therapeutics, is due to take the top job at Teva on 1 January, and will serve as the pharma company’s president.

Sales 59

Sales Medicine FDA Pharma 59

Pharma Leaders

JUNE 27, 2023

Pfizer obtained the licence for gene therapy from Spark Therapeutics in December 2014. Fidanacogene elaparvovec also demonstrated to be well-tolerated, with a safety profile in line with Phase I/II data.

Food and Drug Administration 52

Food and Drug Administration FDA Safety Engineering 52

pharmaphorum

JANUARY 27, 2023

While global macroeconomic uncertainty continues to impact financing, the pharma industry has focused on UK biotechs to strengthen product pipelines. The UK BioIndustry Association (BIA) and data and insights company Clarivate have released their annual UK Biotech Financing report – and, on the whole, the findings are not positive.

Pharma 52

Pharma Manufacturing Medicine Biopharma 52

pharmaphorum

AUGUST 19, 2022

Also vying for market share is BioCryst Pharma’s Orladeyo (berotralstat), which is given orally once a day and is being targeted towards HAE patients with fewer attacks as well as those with difficult venous access and needle phobia. It is administered as an intravenous injection.

Sales 52

Sales Pharma Patients Medicine 52

pharmaphorum

JANUARY 23, 2023

Morphic Therapeutic has lost Johnson & Johnson’s Janssen Pharma as a partner, following the termination of an alliance to develop drugs targeting integrins first agreed in 2019. In a filing with the Securities and Exchange Commission (SEC). ” It was modified again in the middle of 2021.

Safety 52

Safety FDA Pharma 52